A Real‐World Study on Adverse Reactions of Belimumab Based on the FDA Adverse Event Reporting System Database

Documenti analoghi

• A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid
  di: Le Hai, et al.
  Pubblicazione: (2025)
• Adverse Events Associated With Dabrafenib, Trametinib, and Their Combination Therapy: A Disproportionality Analysis of the FDA Adverse Event Reporting System ( FAERS ) Database
  di: Zhenpo Zhang, et al.
  Pubblicazione: (2025)
• A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis‐Related Safety Signals
  di: Priscilla O. M. V. Lopes, et al.
  Pubblicazione: (2026)
• Adverse Event Assessment of Upadacitinib: A Pharmacovigilance Study Based on the FAERS Database
  di: Jiayu Yuan, et al.
  Pubblicazione: (2024)
• Aioli: Standardising Drugs in the FDA Adverse Event Reporting System ( FAERS ) to RxNorm and Anatomical Therapeutic Chemical ( ATC ) Codes
  di: Rowan E. Parry, et al.
  Pubblicazione: (2025)